Talk:Cardiovascular System - Heart Valve Development: Difference between revisions
From Embryology
(Created page with '==2009== ===Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation=== Araki T, Chan G, Newbigging S, Morika…') |
No edit summary |
||
| Line 1: | Line 1: | ||
==2010== | |||
Regulation of heart valve morphogenesis by Eph receptor ligand, ephrin-A1 | |||
http://onlinelibrary.wiley.com/doi/10.1002/dvdy.22458/full | |||
===Wnt signaling in heart valve development and osteogenic gene induction=== | |||
Alfieri CM, Cheek J, Chakraborty S, Yutzey KE. | |||
Dev Biol. 2010 Feb 15;338(2):127-35. Epub 2009 Dec 1. | |||
PMID: 19961844 | |||
==2009== | ==2009== | ||
===Heart valve development: regulatory networks in development and disease=== | |||
Combs MD, Yutzey KE. | |||
Circ Res. 2009 Aug 28;105(5):408-21. Review. | |||
PMID: 19713546 | |||
===Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation=== | ===Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation=== | ||
Revision as of 13:47, 21 October 2010
2010
Regulation of heart valve morphogenesis by Eph receptor ligand, ephrin-A1
http://onlinelibrary.wiley.com/doi/10.1002/dvdy.22458/full
Wnt signaling in heart valve development and osteogenic gene induction
Alfieri CM, Cheek J, Chakraborty S, Yutzey KE. Dev Biol. 2010 Feb 15;338(2):127-35. Epub 2009 Dec 1. PMID: 19961844
2009
Heart valve development: regulatory networks in development and disease
Combs MD, Yutzey KE. Circ Res. 2009 Aug 28;105(5):408-21. Review. PMID: 19713546
Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation
Araki T, Chan G, Newbigging S, Morikawa L, Bronson RT, Neel BG. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4736-41. Epub 2009 Feb 27. PMID: 19251646
